Success Metrics

Clinical Success Rate

87.5%

Based on 7 completed trials

Completion Rate

88%(7/8)

Active Trials

0(0%)

Results Posted

14%(1 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_3

25%

Ph not_applicable

38%

Ph phase_2

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

2(25.0%)

N/ANon-phased studies

3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Terminated(1)

Detailed Status

Completed7

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (37.5%)

Phase 32 (25.0%)

N/A3 (37.5%)

Trials by Status

completed788%

terminated113%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_3

Clinical Trials (8)

Showing 8 of 8 trials

NCT05890534Phase 3

Pycnogenol® in Post-COVID-19 Condition

Completed

NCT02909686Not Applicable

Effects of Botanical Microglia Modulators in Gulf War Illness

Completed

NCT05786820Not Applicable

Impact of Pycnogenol® on Gingival Inflammation

Completed

NCT02700685Phase 3

Effect of Pycnogenol® on ADHD

Completed

NCT00214032Phase 2

Pycnogenol for the Treatment of Lymphedema

Completed

NCT00952627Phase 2

Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects

Terminated

NCT00641758Not Applicable

Pycnogenol and Endothelial Function in Coronary Artery Disease

Completed

NCT00064857Phase 2

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8